Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 9k
26 March 2020
E-001887/2020
Question for written answer
to the Commission
Rule 138
Eva Kaili
 Subject: Common space framework for health data exchange amid the COVID-19 outbreak in Europe

The unprecedented rate of the COVID-19 outbreak in Europe is putting tremendous pressure on the healthcare systems of Member States. The exponential contagion rate in Europe calls for a coordinated and proactive sharing of information in order to improve the preparedness of healthcare systems, anticipate outbreak peaks more accurately, and apply appropriate measures more effectively. Data on patients and healthcare systems across Europe are central to the modelling efforts of the executive authorities at both national and European levels. The availability of patient data and healthcare systems around Europe is key to extrapolating results, anticipating future developments and identifying risks and vulnerable groups. It is important to take appropriate decisions now in order to protect citizens and minimise the strain on healthcare systems.

1. What framework is in place for sharing healthcare and/or patient data and what safeguards are in place to prevent harmful manipulation or extraction?

2. What are the provisions for the anonymisation and retention of sensitive information that includes healthcare and geolocation data among sharing entities?

3. Are there provisions in place to ensure that data shared with private companies in specific industries (i.e. pharmaceutical) is used exclusively for the containment of COVID-19 and not any other business activity that could generate a profit?

Last updated: 7 April 2020Legal notice - Privacy policy